USP5 has been reported to play vital roles in tumor progression in various cancers, including pancreatic cancer, liver cancer, and colorectal cancer (Liu et al., 2017; Li et al., 2017; Xu et al., 2019). This evidence concerns the gene USP5 and familial pancreatic carcinoma.